UiPath 2026 Q3 Earnings Record Net Income Surges 1966% Amid Revenue Growth

Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Tuesday, Dec 9, 2025 6:10 am ET1min read
PATH
--
Aime RobotAime Summary

-

UiPath
(PATH) reported a 1966% net income surge to $198.84M in Q3 2026, reversing a $10.65M loss, driven by 15.9% revenue growth to $411.11M.

- Shares rose 36.61% weekly but post-earnings trading strategies underperformed with -41.50% returns, contrasting the stock's 19-month high.

- Executives sold $1.37M in shares post-earnings while CEO Ashim Gupta highlighted operational improvements as key to the company's turnaround.

- The profit rebound reflects improved cost management, positioning UiPath for long-term stability after years of financial challenges.

UiPath (PATH) delivered a strong earnings report for Q3 2026, reversing years of losses with a net income of $198.84 million—up from a $10.65 million loss in the prior year. The company also exceeded revenue expectations and provided bullish guidance for the remainder of the fiscal year.

Revenue

UiPath’s total revenue rose 15.9% year-over-year to $411.11 million in Q3 2026, driven by robust performance across all segments. Licensing revenue stood at $150.04 million, while subscription services contributed $247.57 million, reflecting sustained demand for its automation platform. Professional services and other revenue added $13.50 million, completing the $411.11 million total.

Earnings/Net Income

The company returned to profitability with an EPS of $0.37, a dramatic turnaround from a $0.02 loss per share in 2025 Q3. Net income surged 1966.2% to $198.84 million, marking the first GAAP-profitable third quarter in its history. This reversal highlights improved cost management and operational efficiency, positioning

UiPath
for long-term financial stability.

Price Action

PATH’s stock surged 36.61% in the most recent full trading week and gained 32.58% month-to-date. On the latest trading day, shares edged up 1.10%, extending a six-day winning streak.

Post-Earnings Price Action Review

The strategy of buying

PATH
following a positive earnings report and holding for 30 days underperformed significantly, delivering a -41.50% return compared to a 53.21% benchmark. Despite a maximum drawdown of 0.00% (indicating no losses during the backtest period), the approach failed to capture gains, resulting in a CAGR of -12.20% and a Sharpe ratio of -0.18.

Additional News

UiPath insiders executed prearranged trading plan sales in the week following the earnings report. Brad Brubaker, an officer, sold 27,580 shares ($511.7K) at $18.55 on Dec 5, 2025, while Chairman Daniel Dines sold 45,000 shares ($864.6K) at $19.21 on Dec 8, 2025. Separately, the company’s stock hit a 19-month high after the earnings beat, with CEO Ashim Gupta highlighting operational improvements as key to its turnaround.

Comments



Add a public comment...
No comments

No comments yet